Thierry Laugel

Thierry Laugel is the current Director at Ermium Therapeutics. Prior to this, they have held positions at Flamel, AGF Private Equity, and CDC Innovation. Laugel has been in the field of research and development for over two decades. Thierry has a wealth of experience in portfolio management, private equity, and healthcare investments.

Thierry Laugel has an MBA from INSEAD and a PhD in Pharmacology from Paris-Sud University (Paris XI). Thierry also has a Doctor of Pharmacy (Pharm.D.) from Université Louis Pasteur (Strasbourg I).